3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
6
Leukemia, Myeloid, Acute
4
Uveal Melanoma
2
Lymphoma
2
Leukemia
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
Recurrence
1
Rectal Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Meningeal Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Myeloid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Kidney Diseases
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Interventions
Cyclophosphamide
3
Gemcitabine
2
regorafenib
1
liposomal doxorubicin
1
lenvatinib
1
fludarabine
1
alectinib
1
aldesleukin
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Restraint, Physical
1
Range of Motion, Articular
1
Quality of Life
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Metastasectomy
1
Masks
1
Lomustine
1
Irinotecan
1
Ipilimumab
1
Everolimus
1
Etoposide
1
Doxorubicin
1
Data Collection
1
Cisplatin
1
Carboplatin
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Interleukin-2
×
90 days
×
Clear all
No trials found.